Comparing Ultra High-Resolution CT to Conventional CT for Heart Disease
Official title: Ultra-High Resolution Computed Tomography (CT) vs. Conventional CT for Detecting Obstructive Coronary Artery Disease (CAD) The CORE-COMPARE Pilot Study
Run by Johns Hopkins University · NCT06170541 · Data updated 2026-11-12
This study is testing whether a new type of heart scan called Ultra High-Resolution CT can find heart disease better than the regular CT scan in people who are at lower risk.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 21 Years to 85 Years |
| Sex | All |
| Enrollment | 140 (estimated) |
| Sponsor | Johns Hopkins University Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Baltimore, Maryland) |
| Status | Recruiting |
| Started | April 5, 2021 |
| Main results expected | December 2026 |
| Study ends | December 2027 |
| Registry record updated | April 13, 2026 |
| Trial ID | NCT06170541 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 21-85 with a clinical history suggestive of coronary heart disease referred for further evaluation via CT angiography.
✕Probably not a fit
Patients with known allergies to iodinated contrast media or severe heart conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the effectiveness of Ultra High-Resolution Computed Tomography (UHR-CT) compared to conventional CT in identifying obstructive coronary heart disease (CHD) in a lower-risk population. Participants will undergo a single scan using UHR-CT, which allows for the reconstruction of conventional resolution images from the same data, minimizing radiation exposure and scan time. The primary goal is to gather preliminary data to support the hypothesis that UHR-CT is superior in detecting CHD. This approach aims to justify the broader implementation of UHR-CT technology in clinical practice.
Why it matters
Potential benefit: If successful, this study could lead to improved noninvasive detection of coronary heart disease, enhancing patient outcomes.
How similar studies have gone: While the specific use of UHR-CT in this context is novel, similar studies have shown promise in improving imaging techniques for cardiovascular conditions.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients aged 21-85 years * Clinical history suggestive of CHD who are referred by their primary cardiologist for further evaluation via Computed tomography angiography (CTA) will be asked to participate. * Women of child bearing potential must demonstrate a negative pregnancy test within 24 hours of the study CTA. * Ability to understand and willingness to sign the Informed Consent Form. Exclusion Criteria: * Known allergy to iodinated contrast media. * History of multiple myeloma or previous organ transplantation * Elevated serum creatinine (\> 1.5mg/dl) OR calculated creatinine clearance of \< 60 ml/min (using the Cockcroft-Gault formula * Atrial fibrillation or uncontrolled tachyarrhythmia, or advanced atrioventricular block (second or third degree heart block) * Evidence of severe symptomatic heart failure (NYHA Class III or IV); * Known or suspected moderate or severe aortic stenosis * History of prior percutaneous coronary intervention (PCI) in one or more vessel or history of coronary arterial bypass grafting (CABG) * Suspected acute coronary syndrome * Presence of any other history or condition that the investigator feels would be problematic
Where it's running
-
Johns Hopkins School of Medicine
Baltimore, Maryland, United States Recruiting
Study contacts
- Principal investigator: Joao Lima, Professor — Md
- Study coordinator: Joao Lima, Professor
- Email: jlima@jhmi.edu
- Phone: 4106141284
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Single vs. dual antiplatelet therapy after drug-coated balloon PCI in coronary disease
This trial tests whether a single antiplatelet drug after a drug-coated balloon PCI is as safe and effective as the usual two-drug approach in adults with coronary disease.
-
AI-driven prediction of non-target coronary lesion progression after PCI
This project will test an AI tool that uses clinical data, blood biomarkers, and coronary imaging to see if it can predict which adults treated with PCI are likely to have progression of non-target coronary lesions.
-
Closed-loop brain neurofeedback on the left prefrontal cortex to lower stress-related heart responses in people with coronary heart disease and anxiety.
This trial will test whether closed‑loop fNIRS neurofeedback aimed at the left dorsolateral prefrontal cortex can lower heart rate during a cold‑pain stress test in adults with stable coronary heart disease and anxiety.
-
Closed-loop neurofeedback targeting the right prefrontal cortex to improve heart regulation in people with coronary heart disease and anxiety
This trial will try real-time fNIRS neurofeedback aimed at the right dorsolateral prefrontal cortex to lower sympathetic heart activity and improve heart rate variability in right-handed adults with stable coronary heart disease and DSM-5 anxiety.
-
Community- or home-based exercise for adults with weakened heart or lungs
This test will see if an eight-week, community- or home-based exercise program can improve heart and lung function in adults 18–85 with reduced cardiopulmonary fitness.
-
Village-based program to manage chronic heart conditions in Qujiang older adults
This project will try a village-based program combining medicines, lifestyle support, education, and 7-day ECG monitoring for people aged 60+ in Qujiang with chronic heart conditions such as atrial fibrillation, high blood pressure, coronary artery disease, or heart failure.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.